These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12536981)

  • 21. Re: Devani et al. Dental extractions in patients on warfarin: is alteration of anti-coagulant regime necessary?
    Fordyce A; Bailey BM
    Br J Oral Maxillofac Surg; 1999 Apr; 37(2):150. PubMed ID: 10371325
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration.
    Rosborough TK; Jacobsen JM; Shepherd MF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical application of the 10-mg warfarin initiation nomogram.
    Wells PS; Le Gal G; Tierney S; Carrier M
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):403-8. PubMed ID: 19521238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An audit of INR control in the Australian indigenous setting.
    Pickering A; Thomas DP
    Aust Fam Physician; 2007 Nov; 36(11):959-60, 967. PubMed ID: 18043786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of the dental patient on anticoagulant medication.
    Rada RE
    Dent Today; 2006 Aug; 25(8):58-63. PubMed ID: 16925162
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching.
    Halkin H; Shapiro J; Kurnik D; Loebstein R; Shalev V; Kokia E
    Clin Pharmacol Ther; 2003 Sep; 74(3):215-21. PubMed ID: 12966365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous warfarin as an alternative for anticoagulation.
    Gellatly RM
    Pharmacotherapy; 2007 Jun; 27(6):933-5. PubMed ID: 17542775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dental extractions and anticoagulants.
    Brownbill JW
    Aust Dent J; 2003 Dec; 48(4):267-8; author reply 268. PubMed ID: 14738133
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical inquiries. What is the interval for monitoring warfarin therapy once therapeutic levels have been achieved?
    Meurer LN; Jamieson B; Guthmann R
    J Fam Pract; 2005 Feb; 54(2):171-2. PubMed ID: 15689295
    [No Abstract]   [Full Text] [Related]  

  • 30. Reducing the risk for stroke in patients who have atrial fibrillation.
    Garcia DA; Hylek E
    Cardiol Clin; 2008 May; 26(2):267-75, vii. PubMed ID: 18406999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Warfarin home monitoring program expanded.
    Harv Heart Lett; 2008 Jun; 18(10):7. PubMed ID: 18822511
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors.
    Spinler SA; Nutescu EA; Smythe MA; Wittkowsky AK
    Ann Pharmacother; 2005 Jun; 39(6):1049-55. PubMed ID: 15855245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective assessment of bleeding and international normalized ratio in warfarin-anticoagulated patients having cutaneous surgery.
    Syed S; Adams BB; Liao W; Pipitone M; Gloster H
    J Am Acad Dermatol; 2004 Dec; 51(6):955-7. PubMed ID: 15583588
    [No Abstract]   [Full Text] [Related]  

  • 34. [Massive metrorrhagia in a patient under warfarin anticoagulation. Rapid reversal with a concentrated prothrombin complex (Prothromplex Immuno TIM 4 600 IU)].
    Fuentes Pradera MA; Suárez Delgado JM; Yanes Vidal G; Yerga Pozo G
    Rev Esp Anestesiol Reanim; 2006 Dec; 53(10):669-71. PubMed ID: 17302086
    [No Abstract]   [Full Text] [Related]  

  • 35. Interaction between warfarin and nafcillin: case report and review of the literature.
    Kim KY; Frey RJ; Epplen K; Foruhari F
    Pharmacotherapy; 2007 Oct; 27(10):1467-70. PubMed ID: 17896903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perioperative bridging therapy for the at-risk patient on chronic anticoagulation.
    Spyropoulos AC
    Dis Mon; 2005; 51(2-3):183-93. PubMed ID: 15900271
    [No Abstract]   [Full Text] [Related]  

  • 37. Anticoagulants to prevent stroke occurrence and worsening.
    Caplan LR
    Isr Med Assoc J; 2006 Nov; 8(11):773-8. PubMed ID: 17180829
    [No Abstract]   [Full Text] [Related]  

  • 38. [Start warfarin treatment with provocation].
    Schnell R
    Lakartidningen; 2008 Oct 8-14; 105(41):2864-5. PubMed ID: 19013847
    [No Abstract]   [Full Text] [Related]  

  • 39. Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting.
    Sobieraj-Teague M; Daniel D; Farrelly B; Coghlan D; Gallus A
    Thromb Res; 2009 Apr; 123(6):909-13. PubMed ID: 19042011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Provocation at the initiation of warfarin treatment].
    Odén A; Fahlén M
    Lakartidningen; 2008 Sep 10-16; 105(37):2500. PubMed ID: 19009696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.